D.E. Shaw & Co
CDMO

D.E. Shaw & Co’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

D.E. Shaw & Co’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-235,175
Closed -$2.9M – 4877
2024
Q4 		$2.9M Sell
235,175
-430,331
-65% -$4.93M ﹤0.01% 2422
2024
Q3 		$7.57M Buy
665,506
+247,129
+59% +$2.48M 0.01% 1623
2024
Q2 		$2.99M Buy
418,377
+250,068
+149% +$1.91M ﹤0.01% 2263
2024
Q1 		$1.13M Buy
168,309
+12,001
+8% +$82.6K ﹤0.01% 3015
2023
Q4 		$1.02M Buy
156,308
+51,680
+49% +$333K ﹤0.01% 3128
2023
Q3 		$988K Buy
+104,628
New +$1.26M ﹤0.01% 3068
2023
Q2 		– Sell
-23,479
Closed -$440K – 4651
2023
Q1 		$440K Buy
+23,479
New +$386K ﹤0.01% 3613
2021
Q4 		– Sell
-55,521
Closed -$1.2M – 5782
2021
Q3 		$1.2M Buy
55,521
+28,200
+103% +$681K ﹤0.01% 3460
2021
Q2 		$701K Sell
27,321
-28,063
-51% -$599K ﹤0.01% 3828
2021
Q1 		$1.01M Sell
55,384
-3,214
-5% -$53.4K ﹤0.01% 3101
2020
Q4 		$676K Buy
+58,598
New +$536K ﹤0.01% 3245
2020
Q2 		– Sell
-25,332
Closed -$129K – 4300
2020
Q1 		$129K Sell
25,332
-168,704
-87% -$1.02M ﹤0.01% 3748
2019
Q4 		$1.49M Buy
+194,036
New +$1.13M ﹤0.01% 2699
2019
Q2 		– Sell
-14,493
Closed -$62K – 3923
2019
Q1 		$62K Hold
14,493
– – ﹤0.01% 3509
2018
Q4 		$59K Buy
14,493
+4,444
+44% +$23.2K ﹤0.01% 3676
2018
Q3 		$69K Buy
+10,049
New +$59.6K ﹤0.01% 3642
2016
Q4 		– Sell
-91,280
Closed -$275K – 3642
2016
Q3 		$275K Buy
91,280
+32,645
+56% +$87.7K ﹤0.01% 3084
2016
Q2 		$149K Buy
58,635
+34,716
+145% +$96.8K ﹤0.01% 3214
2016
Q1 		$70K Buy
+23,919
New +$128K ﹤0.01% 3310
2015
Q3 		– Sell
-9,174
Closed -$84K – 3939
2015
Q2 		$84K Buy
+9,174
New +$88.2K ﹤0.01% 3665
2014
Q3 		– Sell
-4,100
Closed -$54K – 4431
2014
Q2 		$54K Buy
+4,100
New +$51.7K ﹤0.01% 4105

Other funds holding CDMO

TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

D.E. Shaw & Co's CDMO Position: Q1 2025 in Review

D.E. Shaw & Co sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 235,175 shares — an estimated $2.9M sold.

D.E. Shaw & Co first reported a position in CDMO in Q2 2014 and held it in 21 quarters. The position peaked at $7.57M in Q3 2024. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

  • D.E. Shaw & Co reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • D.E. Shaw & Co sold 235,175 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $2.9M.
  • D.E. Shaw & Co first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2014 and held it in 21 quarters.
  • D.E. Shaw & Co's Avid Bioservices, Inc. Common Stock position peaked at $7.57M in Q3 2024.
  • 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on D.E. Shaw & Co's 13F filing for Q1 2025, filed 15 May 2025.